Contract award notice
Results of the procurement procedure
Section I: Contracting
entity
I.1) Name and addresses
University Hospitals of North Midlands NHS Trust
Royal Stoke University Hospial, Newcastle Road
Stoke on Trent
ST4 6QG
UK
Contact person: Head of Procurement (Strategic Medical)
E-mail: lisa.buckley@uhnm.nhs.uk
NUTS: UKG
Internet address(es)
Main address: https://www.uhnm.nhs.uk/
Address of the buyer profile: https://www.uhnm.nhs.uk/
I.4) Type of the contracting authority
Body governed by public law
I.5) Main activity
Health
Section II: Object
II.1) Scope of the procurement
II.1.1) Title
Urine-Based Molecular Testing Service
Reference number: MED9962
II.1.2) Main CPV code
85100000
II.1.3) Type of contract
Services
II.1.4) Short description
Urine-Based Molecular Testing Service
II.1.6) Information about lots
This contract is divided into lots:
No
II.1.7) Total value of the procurement
Value excluding VAT:
84 600.00
GBP
II.2) Description
II.2.3) Place of performance
NUTS code:
UKG23
II.2.4) Description of the procurement
This is a contract for a Urine-Based Molecular Testing Service. <br/><br/>This Notice is an Intention to Award a Contract under the Most Suitable Provider Process, following the F01 Prior Information Notice issued on 7 August 20026 (2026/S 000-075257).<br/><br/>The approximate lifetime value of the contract is £84,600. <br/><br/>This is a new service with a new provider. <br/><br/>The estimated dates between which the services are intended to be provided are; 20 November 2026 to 31 March 2027.
II.2.5) Award criteria
Price
II.2.11) Information about options
Options:
Yes
Description of options:
This contract includes an option to extend for up to 6 months.
II.2.13) Information about European Union funds
The procurement is related to a project and/or programme financed by European Union funds:
No
Section IV: Procedure
IV.1) Description
IV.1.1) Type of procedure
Award of a contract without prior publication of a call for competition
Justification for selected award procedure:
The procurement falls outside the scope of application of the Directive
Explanation
This is a Provider Selection Regime (PSR) intention to award notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contracts Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to decision makers by midnight on Thursday 19 November 2026. This contract has not yet formally been awarded; this notice services as an intention to award under the PSR.
IV.1.8) Information about Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement:
No
Section V: Award of contract
A contract/lot is awarded:
Yes
V.2 Award of contract
V.2.1) Date of conclusion of the contract
09/11/2026
V.2.2) Information about tenders
Number of tenders received: 2
The contract has been awarded to a group of economic operators:
No
V.2.3) Name and address of the contractor
Informed Genomics Trading as Nonacus Clinical Services
Unit 5 Quinton Business Park
Quinton
B32 1AF
UK
NUTS: UKG31
Internet address(es)
URL: www.nonacus.com
The contractor is an SME:
Yes
V.2.4) Information on value of the contract/lot (excluding VAT)
Initial estimated total value of the contract/lot:
Total value of the contract/lot:
: 84 600.00
GBP
V.2.5) Information about subcontracting
Section VI: Complementary information
VI.3) Additional information
This is a Provider Selection Regime (PSR) Intention to Award Notice. The awarding of this contract is subject to the Health Care Services (Provider Selection Regime) Regulations 2023. For the avoidance of doubt, the provisions of the Public Contract Regulations 2015 do not apply to this award. The standstill period begins on the day after the publication of this notice. Representations by providers must be made to the relevant authority by midnight on Thursday 19 November 2026. <br/><br/>This contract has not been formally awarded: this serves as an intention to award under the PSR. <br/><br/>Representations should be issued to Lisa.Buckley@uhnm.nhs.uk. <br/><br/>The Award Decision Makers are: <br/><br/>Procurement Lead (Head of Procurement - Medical Strategic)<br/>Divisional Business Advisor (Head of Operations - Surgical Division)<br/>Deputy Group Director of Procurement<br/>Deputy Chief Finance Officer<br/><br/>No declared Conflicts of Interest were received as part of the decision-making process. <br/><br/>The Trust undertook an assessment against the following key criteria: <br/><br/>KC1: Quality and Innovation (Weighting 30%)<br/>KC2: Value (Weighting 25%)<br/>KC3: Integration, Collaboration and Service Sustainability (Weighting 15%)<br/>KC4: Improving Access, Reducing Health Inequalities and Facilitating Choice (Weighting 20%)<br/>KC5: Social Value (Weighting 10%)<br/><br/>The weightings were allocated in accordance with the relative importance in line with the Service Specification. <br/><br/>Following an internal assessment, it was identified that Informed Genomics (t/a Nonacus Clinical Services) met the Key Criteria to a sufficient standard.
VI.4) Procedures for review
VI.4.1) Review body
Independent Choice and Procurement Panel.
Wellington House
London
SE1 8UG
UK
Internet address(es)
URL: https://www.england.nhs.uk
VI.4.2) Body responsible for mediation procedures
Centre for Effective Dispute Resolution
70 Fleet Street
London
EC4Y 1EU
UK
E-mail: info@cedr.com
Internet address(es)
URL: https://www.cedr.com/
VI.5) Date of dispatch of this notice
09/11/2026